These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7671365)

  • 1. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
    Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
    J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
    Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
    Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
    Hernández D; Lacalzada J; Salido E; Linares J; Barragán A; Lorenzo V; Higueras L; Martín B; Rodríguez A; Laynez I; González-Posada JM; Torres A
    Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
    Buck PC; Fernandes F; Arteaga E; Matsumoto AY; Araujo AQ; Oliveira EM; Ianni BM; Ramires FJ; Krieger JE; Mady C
    Braz J Med Biol Res; 2009 Aug; 42(8):717-21. PubMed ID: 19390744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme gene polymorphism on the left-ventricular function and mass in patients with acromegaly.
    Erbas T; Alikasifoglu M; Aksöyek S; Unsal I; Gedik O; Tuncbilek E
    Cardiology; 1999; 92(4):226-31. PubMed ID: 10844381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy.
    Ueno H; Takata M; Yasumoto K; Tomita S; Inoue H
    Jpn Heart J; 1999 Sep; 40(5):589-98. PubMed ID: 10888379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
    Patel R; Lim DS; Reddy D; Nagueh SF; Lutucuta S; Sole MJ; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2000 Dec; 32(12):2369-77. PubMed ID: 11113012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.
    Yildiz A; Akkaya V; Hatemi AC; Cine N; Tükek T; Görçin B; Demirel S; Türk S; Sever MS
    Nephron; 2000 Feb; 84(2):130-5. PubMed ID: 10657713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.
    Doolan G; Nguyen L; Chung J; Ingles J; Semsarian C
    Int J Cardiol; 2004 Aug; 96(2):157-63. PubMed ID: 15314809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women].
    Orłowska-Baranowska E; Placha G; Gaciong Z; Zakrzewski D; Baranowski R; Kuśmierczyk-Droszcz B; Hoffman P; Rawczyńska-Englert I
    Pol Arch Med Wewn; 2002 Sep; 108(3):855-66. PubMed ID: 12600182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.